Epsilon M&A Deal Report - LXV Remedies Holdings (McCauley Pharmacy Group)

Transaction Multiples for the Valuation of Private Companies

UniPhar > LXV Remedies Holdings (McCauley Pharmacy Group)

Announced Date : 20 September 2022

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : UniPhar

Target: LXV Remedies Holdings (McCauley Pharmacy Group)

Target Country: Ireland

Sector of activity : Retail and Wholesale ('R&W')

Business Description :

> McCauley Pharmacy Group ("McCauley") operates pharmacies.

No EMAT : 110405

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Retail and Wholesale ('R&W')) = 1099

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
30/06/2021 Europris Lekekassen Norway 0
29/04/2022 G-III Apparel Group Karl Lagerfeld Netherlands 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database